Literature DB >> 7094932

Sideroblastic anaemia. A review of seven paediatric cases.

B C Hamel, E D Schretlen.   

Abstract

Sideroblastic Anaemias are characterised by a) chronic hypochromic anemia, b) ringed sideroblasts in the bone marrow, c) an increase in total body iron, d) ineffective erythropoiesis and e) often abnormal concentrations of F.E.P. A classification of Sideroblastic Anaemia is given and the pathophysiology of Sideroblastic Anaemia is discussed. A series of seven paediatric cases with Sideroblastic Anaemia is presented and the results of studies of the iron, vitamin B6 and porphyrin metabolism are discussed. In two cases arguments for an ALA-synthetase deficiency are given. All five males were diagnosed as hereditary X-linked Sideroblastic Anaemia, one female as I.R.S.A. and the other female, who showed the features of the X-linked type, as congenital Sideroblastic Anaemia.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7094932     DOI: 10.1007/BF00441138

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  29 in total

1.  SIDEROBLASTIC ANAEMIA IN MAN: OBSERVATIONS ON SEVENTY CASES.

Authors:  B H MACGIBBON; D L MOLLIN
Journal:  Br J Haematol       Date:  1965-01       Impact factor: 6.998

2.  Effect of pyridoxine plus chronic phlebotomy on the function and morphology of bone marrow and liver in pyridoxine-responsive sideroblastic anemia.

Authors:  J D Hines
Journal:  Semin Hematol       Date:  1976-04       Impact factor: 3.851

Review 3.  Erythropoiesis and iron kinetics.

Authors:  I Cavill; C Ricketts
Journal:  Br J Haematol       Date:  1978-04       Impact factor: 6.998

4.  Familial sideroblastic anaemia: problem of Xg and X chromosome inactivation.

Authors:  D J Weatherall; M E Pembrey; E G Hall; R Sanger; P Tippett; J Gavin
Journal:  Lancet       Date:  1970-10-10       Impact factor: 79.321

5.  Measurement of delta-aminolevulinic acid synthetase activity in human erythroblasts.

Authors:  Y Aoki; G Urata; O Wada; F Takaku
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

6.  The regulation of porphyrin and heme synthesis.

Authors:  A Kappas; R D Levere; S Granick
Journal:  Semin Hematol       Date:  1968-10       Impact factor: 3.851

7.  A comparative electron microscopic study of refractory and alcoholic sideroblastic anaemia.

Authors:  J A Grasso; J D Hines
Journal:  Br J Haematol       Date:  1969-07       Impact factor: 6.998

8.  [Various aspects of iron metabolism].

Authors:  H G van Eijk; C van der Heul
Journal:  Ned Tijdschr Geneeskd       Date:  1978-11-11

9.  The response of free erythrocyte protoporphyrin to pyridoxine therapy in a patient with sideroachrestic (sideroblastic) anemia.

Authors:  G R Lee; G E Cartwright; M M Wintrobe
Journal:  Blood       Date:  1966-04       Impact factor: 22.113

10.  Bone marrow delta-aminolaevulinate synthase deficiency in a female with congenital sideroblastic anemia.

Authors:  G R Buchanan; S S Bottomley; R Nitschke
Journal:  Blood       Date:  1980-01       Impact factor: 22.113

View more
  4 in total

1.  Enzymatic defect in "X-linked" sideroblastic anemia: molecular evidence for erythroid delta-aminolevulinate synthase deficiency.

Authors:  P D Cotter; M Baumann; D F Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

2.  Hereditary sideroblastic anaemia and ataxia: an X linked recessive disorder.

Authors:  R A Pagon; T D Bird; J C Detter; I Pierce
Journal:  J Med Genet       Date:  1985-08       Impact factor: 6.318

3.  A paediatric case of sideroblastic anaemia. Ultrastructural studies of erythroblasts cultured from marrow BFU-E in a methylcellulose micromethod.

Authors:  M Claustres; H Vannereau; H Bellet; G Margueritte; C Sultan
Journal:  Eur J Pediatr       Date:  1986-10       Impact factor: 3.183

Review 4.  Pyridoxine-refractory congenital sideroblastic anaemia with evidence for autosomal inheritance: exclusion of linkage to ALAS2 at Xp11.21 by polymorphism analysis.

Authors:  P E Jardine; P D Cotter; S A Johnson; E J Fitzsimons; L Tyfield; P W Lunt; D F Bishop
Journal:  J Med Genet       Date:  1994-03       Impact factor: 6.318

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.